Free Delivery on All Orders Over $250
🧳 Free Shockproof Carrying Case on Orders Over $150
Third-Party Tested & COA Verified — Every Batch
Retatrutide 20mg $150.00
Retatrutide 20mg — Truth Bio Labs research peptide
Retatrutide 20mg view 2 — Truth Bio Labs research peptide

Retatrutide 20mg

Triple-Agonist Peptide for Metabolic & Endocrine Pathway Research

🎁 FREE 3ml Bacteriostatic Water with Every Vial Purchased

Every peptide vial order automatically includes a complimentary 3ml vial of bacteriostatic water at no extra cost.

$150.00

Availability: 50 in stock

  • 99%+ Purity Tested
  • Canadian Lab Tested
  • Ships from Toronto, Ontario
  • Free Bacteriostatic Water with Every Order

Overview

Retatrutide is a synthetic peptide studied for its activity across three metabolic hormone receptor pathways:

  • Glucagon-like peptide-1 (GLP-1)
  • Glucose-dependent insulinotropic polypeptide (GIP)
  • Glucagon (GCGR)

In research settings, Retatrutide is examined as a multi-receptor signaling model for investigating metabolic regulation, energy balance, and endocrine system coordination.

Due to its triple-agonist profile, Retatrutide is frequently referenced in metabolic, obesity, energy expenditure, and endocrine signaling research models, where pathway interaction and signal integration are of interest.

For research only !!

Weight0.01 kg
Dimensions5 × 2 × 2 cm

Mechanism of Action

Retatrutide is designed to interact with multiple metabolic hormone receptors, allowing researchers to study coordinated signaling across distinct but interrelated endocrine pathways.

Research indicates Retatrutide engages:

  • GLP-1 receptors, involved in appetite regulation and glucose signaling
  • GIP receptors, associated with nutrient-dependent endocrine responses
  • Glucagon receptors, linked to energy expenditure and metabolic output

This multi-agonist design enables investigation of synergistic and counter-regulatory signaling, making Retatrutide a valuable tool for studying complex metabolic networks rather than isolated pathways.

Research Applications

Metabolic Regulation Research

Retatrutide is widely studied in metabolic signaling models:

  • Energy balance pathway analysis
  • Metabolic rate and substrate utilization signaling
  • Hormonal coordination of nutrient intake and output
  • Integrated metabolic response studies

Triple-agonist activity makes Retatrutide relevant for:

  • Glucose homeostasis pathway modeling
  • Hormonal cross-talk studies
  • Endocrine feedback loop analysis
  • Multi-receptor signaling dynamics

Retatrutide is examined in appetite-related research contexts:

  • Central and peripheral appetite signaling
  • Satiety pathway interaction
  • Energy intake regulation models
  • Neuroendocrine control of feeding behavior

Complex metabolic signaling is central to body composition studies:

  • Adipose tissue signaling pathways
  • Lipid metabolism regulation
  • Energy expenditure vs. storage modeling
  • Weight-regulation signaling research

Metabolic hormones influence cardiovascular systems:

  • Cardiometabolic signaling pathways
  • Lipid and glucose interaction studies
  • Systemic metabolic stress models
  • Endocrine contributions to cardiometabolic balance

Research Advantages

Why Researchers Study Retatrutide

  • Triple-agonist activity in a single peptide
  • Enables study of integrated metabolic signaling
  • Useful for pathway interaction and synergy research
  • Relevant across glucose, appetite, and energy systems
  • Frequently referenced in next-generation metabolic studies

Retatrutide is valued for its systems-level metabolic signaling profile, rather than single-pathway stimulation.

IMPORTANT:
This product is exclusively intended for laboratory research purposes only.
Not approved for human consumption or veterinary use.
Not intended for diagnostic, therapeutic, or consumable applications.

Scientific References

Coskun T, et al. “Triple-agonist peptides for the treatment of metabolic disease.” Cell Metabolism. 2022.
Campbell JE, Drucker DJ. “Pharmacology, physiology, and mechanisms of incretin hormone action.” Cell Metab. 2013.
Holst JJ, et al. “GLP-1, GIP, and glucagon signaling in metabolic regulation.” Nat Rev Endocrinol. 2018.
Finan B, et al. “Unimolecular multi-agonists for metabolic disease.” Trends Endocrinol Metab.

Scroll to Top

Welcome!

I understand these products are for research use only and not for use in people or pets. I am purchasing these items for laboratory or research purposes only. They are not for human or animal use, not medicine, and not for diagnosing, treating, or curing any condition. I will follow all applicable laws and safe handling rules. I accept that this website, and our affiliates, are not responsible for how I use or store these items once delivered, to the fullest extent allowed by law. In accordance with industry guidelines, access to this website is restricted to individuals 21 years of age or older. This site provides information and products strictly for laboratory and research use. Are you over 21 years of age?

I am I am not

Remember Me
Disclaimer: Peptides: This product is intended for laboratory research use only and is not approved for human consumption, medical, or veterinary use. Peptides are sold solely for research and development purposes by qualified professionals. Buyers are responsible for handling all materials in accordance with local regulations and safety guidelines.FDA Disclaimer: The statements made regarding these products have not been evaluated by the Food and Drug Administration. The efficacy of these products has not been confirmed by FDA-approved research. These products are not intended to diagnose, treat, cure, or prevent any disease.